Nikola Baschuk
St. Andrews Place
East Melbourne, VIC 3002, Australia
East Melbourne, VIC 3002, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Editorial Expression of Concern: Recognition of the nonclassical MHC class I molecule H2-M3 by the receptor Ly49A regulates the licensing and activation of NK cells.
Journal: Nature immunology
Published: June 29, 2026
Effectiveness and Safety of Upadacitinib in Treating Oligoarticular and Polyarticular Psoriatic Arthritis: Primary Analysis from the UPJOINT-Study.
Journal: Rheumatology and therapy
Published: July 02, 2025
NK cell heparanase controls tumor invasion and immune surveillance.
Journal: The Journal of clinical investigation
Published: July 01, 2024
Treatment with Upadacitinib in Active Psoriatic Arthritis: Efficacy and Safety Data of the First 192 Patients from the UPJOINT Study, a Multicentre, Observational Study in Clinical Practice.
Journal: Rheumatology and therapy
Published: April 28, 2023
Heparanase is a regulator of natural killer cell activation and cytotoxicity.
Journal: Journal of leukocyte biology
Published: October 25, 2021
Loss of type I IFN responsiveness impairs natural killer cell antitumor activity in breast cancer.
Journal: Cancer immunology, immunotherapy : CII
Published: August 10, 2020
STAT3 serine phosphorylation is required for TLR4 metabolic reprogramming and IL-1β expression.
Journal: Nature communications
Published: August 09, 2019
Oral administration of bovine milk-derived extracellular vesicles induces senescence in the primary tumor but accelerates cancer metastasis.
Journal: Nature communications
Published: July 26, 2019
Leukocyte Heparanase: A Double-Edged Sword in Tumor Progression.
Journal: Frontiers in oncology
Published: February 26, 2019
Neoadjuvant Interferons: Critical for Effective PD-1-Based Immunotherapy in TNBC.
Journal: Cancer immunology research
Published: March 27, 2017
NK cell heparanase controls tumor invasion and immune surveillance.
Journal: The Journal of clinical investigation
Published: January 20, 2017
Eliminating hepatitis B by antagonizing cellular inhibitors of apoptosis.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: April 23, 2015
Last Updated: 09/26/2026